[1]
K. Kraska, “COMPARATIVE CLINICAL OUTCOMES OF FARICIMAB VERSUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: A FOCUSED REVIEW”, IJITSS, vol. 1, no. 3(51), Aug. 2026, doi: 10.31435/ijitss.3(51).2026.6094.